Pharmacy bodies have urged the Health Select Committee to hold the government to account on pharmacy funding and workforce challenges.
In a show of unity, leaders from the sector came together to write a joint letter to the chair of the committee and former health secretary Jeremy Hunt and bring to
his attention how financial pressures worsened by nearly a decade of a real-term decrease in funding have made the sector virtually untenable.
The Pharmaceutical Services Negotiating Committee (PSNC)'s recently published 'Pharmacy Pressures Survey' confirms how this has had an impact on pharmacy contractors,
their teams as well as patients.
The survey found that 91 per cent of pharmacies are experiencing staff shortages. At the same time, demand for community pharmacists has risen - nine in ten pharmacy
teams reported a significant increase in phone calls from patients about prescriptions, and 86 per cent reported a rise in requests for healthcare advice.
The letter to Jeremy Hunt is signed on behalf of the four chief executives of the PSNC, the Association of Independent Multiple Pharmacies (AIMp), the Company
Chemists' Association (CCA) and the National Pharmacy Association (NPA).
A recent survey conducted by YouGov for the National Pharmacy Association (NPA) has highlighted concerning trends in the community pharmacy sector.
The survey published on July 18 and conducted over two days in June this year reveals the subsequent challenges patients face due to the increasing pharmacy
closure rates.
The survey findings, conducted among 2,183 UK adults, indicates that 18 per cent of the respondents reported at least one pharmacy closure in their local area
within the past year.
Specifically, 12 per cent respondents noted closure of one pharmacy, while 6 per cent observed the shutdown of more than one.
These closures are distributed across various regions, underscoring a nationwide issue rather than an isolated one.
Ensuring comprehensive healthcare services for the community necessitates collaboration between pharmacies and GP surgeries. However, several pharmacists
have voiced concerns about a lack of cooperation from their local GPs in implementing the Pharmacy First (PF) service.
In a survey conducted by the National Pharmacy Association (NPA) covering 470 pharmacies across England, three-quarters of pharmacists (77 per cent) indicated
that local GP practices are not appropriately referring patients to the new service.
The survey highlighted instances of patients either not being referred or being referred but found ineligible for support through Pharmacy First. Additionally,
one in five NPA members (19 per cent) felt that their local GP practices were not engaging with the initiative at all.
Commenting on the issue, NPA chair Nick Kaye said: "Feedback from across our network suggests that the rollout of Pharmacy First varies considerably from area
to area.
Eighty-five per cent of adults responding to a survey commissioned by the National Pharmacy Association (NPA) have agreed that community pharmacies are
underfunded and that the sector needs more investment to be able to do the work it does.
The survey of 1,000+ adults in England was carried out online between August 26 and 30 by an agency called Research Without Barriers (RWB) on behalf of the NPA.
Pharmacies in England are now paid less for providing NHS services than they were before the Covid-19 pandemic, after years of real terms cuts.
Seventy-four per cent respondents think it's unfair that community pharmacies in England have had no increase in funding for eight years, despite rising business
costs.
When asked whether it's fair or unfair that pharmacies in England are now paid less for providing NHS services than they were before the pandemic, 81 per cent of
people replied that it's unfair.
There is clear evidence that the majority of distance selling pharmacies are operating in breach of their NHS contracts, and a failure to properly
regulate 'pseudo' distance selling pharmacies is leading to local pharmacy closures, the Company Chemists' Association has reported.
According to the CCA's recent findings, 72 per cent of DSPs dispense over 50 per cent of their prescriptions to patients within a single postcode area within
10 miles of the pharmacy.
"Operating within constrained geographical regions, pseudo-DSPs achieve reduced overheads and operational costs by focusing on localised marketing and medicine
delivery. They compete against local brick-and-mortar pharmacies, causing them to lose vital trade," the CCA claimed, based on its recent survey - The Impact of
Pseudo Distance Selling Pharmacies.
"As per their terms of service, DSPs are obligated to provide prescription delivery nationwide, extending beyond local patients," said the CCA, adding that the
financial savings resulting from the lack of patient access are balanced by the necessity to function on a national scale.
The large majority of adults in the England knew that flu jabs are available in many pharmacies, just over half were aware of the GP Community Pharmacist
Consultation Service or the New Medicine Service, according to a new survey by the National Pharmacy Association (NPA).
The new survey revealed the need to raise the public awareness of key NHS services such as the New Medicine Service.
According to the survey, 56 per cent of those asked believed that pharmacies in England offer NHS consultations for people newly prescribed a medicine for a
long-term condition.
While 48 per cent believed that many pharmacies in England offer blood pressure monitoring (NHS or private). 51 per cent believed it to be true that GPs can
formally refer patients for same-day clinical advice from their local pharmacist about minor ailments.
The National Pharmacy Association (NPA) survey revealed that 93 per cent of respondents experienced 'at least one month' of negative cash flow across their
pharmacy business in 2022.
Nine out of 10 pharmacy owners responding to NPA survey said they made a net loss dispensing medicines for the NHS during 2022, for at least one month of the year.
According to the poll, 48 per cent of them lost money on this core NHS service for six months or more. 45 per cent said their overall outgoings had exceeded overall
income in at least six months of the year.
NPA Chair Andrew Lane said: "This survey shows the bleak financial reality facing many independent pharmacies after years of underfunding. Dispensing at a loss and
negative cashflow is clearly unsustainable."
"This funding crisis must be addressed urgently or pharmacies will fall into a spiral of declining services and ultimately widespread closures, he added. "Tragically,
the story is playing out very much in line with independent research commissioned by the NPA last year, which warned of a nationwide financial emergency in our
sector."
The National Pharmacy Association (NPA), released survey data today (30 October) which suggests Britons have a higher regard for community pharmacies
than retail settings.
It also highlighted the level of awareness of pharmacies' healthcare duties, which range from NHS medicines consultations to monitoring blood pressure.
The survey conducted by Research Without Barriers involved 1680 adults in England from 20-23 October 2023.
The data showed that over 90 per cent of adults in England are aware that pharmacies offer each of these services.
The survey also suggested that 56 per cent of respondents find it appropriate to ask their local pharmacies for help to quit smoking, and 63 per cent would ask
for a blood pressure check.
Patients are highly satisfied with the new Pharmacy First service, which enables pharmacists to assess and treat patients for seven common conditions,
according to a survey by the National Pharmacy Association (NPA).
Nearly 100 NPA members participated in the snapshot poll conducted at the end of the first full week of the service.
Nine in ten respondents (87 per cent) said that "most or all patients expressed satisfaction" with the service they received.
However, many independent community pharmacy owners are facing challenges in implementing the service.
While 56 per cent of pharmacy owners surveyed expressed feeling "motivated" by the new service, a larger proportion (70 per cent) indicated being "under
additional pressure."
More than 30 per cent of the respondents found implementation of the service "harder" than they had expected.
The Royal Pharmaceutical Society's (RPS) second roundtable on workforce wellbeing resulted in a series of collaborative actions to address pharmacy
professionals' mental health and wellbeing challenges.
The roundtable brought together key stakeholders from the pharmacy sector, including organisations like the General Pharmaceutical Council (GPhC), Community
Pharmacy England (CPE), the National Pharmacy Association (NPA), and the profession's independent charity Pharmacist Support (PS).
A report detailing the outcomes of the meeting was published on Friday, highlighting the key areas of discussion and the agreed-upon actions by the participants.
During the roundtable, participants discussed the importance of understanding the workforce demographics, both nationally and locally, and using data to address
wellbeing issues effectively.
They also emphasised the need for using supportive standards set by the General Pharmaceutical Council (GPhC) and the Care Quality Commission (CQC) quality
statement to support and empower pharmacists' wellbeing positively.
More than half of pharmacists working in England are considering changing their roles over the next 12-18 months because of work-related issues, a recent survey by The Pharmacists' Defence Association revealed.
The survey which concluded on February 18, 2022 had more than 2,500 participants including employed and locum pharmacists from all four UK nations.
In the survey, PDA asked respondents about their current roles and future career plans.
The initial feedback showed that unsatisfactory pay and working environments, lack of professional fulfilment, and poor management were the key factors for pharmacy professionals to reconsider their current positions.
Almost nine in ten community pharmacists in England say they have patients who sometimes go without prescription medicines because they cannot afford the
prescription charge levied by the government.
Sixty-eight per cent of pharmacists in a National Pharmacy Association (NPA) survey, conducted via email in June 2022, said this has become more frequent in the
past year - suggesting that the rising cost of living could be leading more people to miss out on vital medicines.
While prescription charge does not apply in Scotland, Wales and Northern Ireland, in England an NHS patients needs to pay £9.35 per item. For patients who need
multiples medicines the cost could be exponential and virtually unaffordable amid rising inflation and higher cost of living.
The survey found that 89 per cent of pharmacies in England have patients who sometimes go without prescription medicines due to cost.
For most pharmacists (74 per cent) this happens one to five times a week. Fifteen per cent said they see such patients from six to 20 times a week.
The Pharmacists' Defence Association (PDA) has undertaken an additional survey of pharmacists employed in the NHS, before deciding to hold their first-ever
ballot for industrial action.
The PDA has more than 7,000 NHS-employed pharmacists in membership and the union is actively considering balloting those members regarding strike action.
The association said: "The experience of some other unions has shown that the government's restrictive rules, designed to make it difficult for working people to
lawfully take industrial action, means trade unions should test members' strength of feeling before balloting."
"Trade unions are not only forced to rely upon postal ballots, but for lawful industrial action to be taken, the result must also meet three tests- at least 50% of
eligible voters must vote; at least 40% of eligible voters must vote 'yes' and a majority of votes must be for 'yes'."
The association is asking members in England, Northern Ireland and, Wales to show if their collective wish, insignificant enough strength, is for strike action. PDA
has emailed the survey to all its members in the NHS in the three nations and will close on Tuesday 3 January.
The Pharmacists Defence Association (PDA) has expressed its keenness to work with the NHS nationally and at the ICB level to discuss how the pharmacist
workforce can most effectively be part of the multidisciplinary team, after the publication of Long-awaited NHS England workforce plan.
Welcoming its publication Alison Jones, PDA Director of Policy said: "It gives greater clarity around the future direction and strategy for professional development,
training, and opportunities for those currently working in the health service or considering their future career. There is a strong emphasis on further development
of the clinical role of pharmacists to support better patient care.
"However, this is a plan that will take years, indeed decades to come to fruition and its success will need to be underpinned by significant funding for its entire
life course.
Workplace pressures, reductions in support staff, and a lack of protected learning time are matters of immediate concern for many PDA members, issues which are
regularly highlighted through activities, such as the safer pharmacies survey.
A recent Pharmacists' Defence Association (PDA) survey revealed that 80 per cent of its member working in the NHS in England, Wales, and Northern Ireland
rejected the NHS pay award.
"For the first time in the history of our union, members have told us they are so angry that they would not rule out industrial action in conjunction with other
NHS unions," said Paul Moloney, PDA Union national officer.
"It is important that, whoever is to lead the government, they listen to this message and act now to ensure our members and others in the NHS do not face swinging
cuts to their standard of living."
PDA members were asked whether they would support industrial action if they had rejected the award and if other NHS unions would be taking industrial action. 58 per
cent of those responding said they would support the PDA Union taking industrial action if members of other unions were also planning to take action on this issue.
For now, however, the PDA Union will wait for other unions to publish the outcomes of their own consultations. As a union dedicated to representing the needs of only
pharmacists, the PDA has been able to quickly survey members immediately after the pay award was announced.
General practitioners (GPs) across England have made a resolute stand against proposed alterations in the 2024/25 national GP General Medical Services (GMS)
contract put forth by the Department of Health and Social Care (DHSC) and NHS England.
This firm opposition coincides with the declaration of an extended six-month strike by 33,869 junior doctors within the NHS, advocating for full pay reinstatement
and reforms in the pay recommendation process.
The latest survey conducted by the British Medical Association (BMA) has revealed that an overwhelming 99.2% of GPs in England are against any changes to the
existing contract.
The proposed amendments, slated for implementation from April 1st, 2024, encompass a meagre national practice contract baseline funding uplift of just 1.9%,
notably falling short of recent inflation rates.
This corroborates with GP Online poll that recently unveiled widespread GP dissatisfaction with proposed changes to the national GMS contract. 83% of GPs in
favour of strikes cite pay and funding concerns, while burnout, high workloads, and patient safety also fuel discontent.
Extending its support for the Prescription Charges Coalition (PCC), the Pharmacists' Defence Association (PDA) is asking pharmacists in England to share their
experiences of patients denying prescriptions due to financial issues.
PDA members who have practiced in the country within the last 12 months are asked to complete the Prescription Charges Coalition survey by Sunday 28 January.
The PCC is an alliance of more than 50 organisations campaigning to abolish unfair prescription charges for people with long-term conditions in England.
All members of the coalition, including PDA and Royal Pharmaceutical Society (RPS), understand that if patients do not receive their prescribed medicines due to the
cost, their health may deteriorate, and this can increase costs for the National Health Service (NHS).